Table of Contents Table of Contents
Previous Page  575 / 1851 Next Page
Information
Show Menu
Previous Page 575 / 1851 Next Page
Page Background

03/01/13

Adjuvant Pembrolizumab after C-RT to st. III NSCLC

Durm ASCO 2017